All Substitutes


Loading...

Disclaimer

Want to know more?
Read Our Editorial Policy

Did you find this information helpful?

    
ZIDOLAM N 300MG/150MG/200MG TABLET_1
ZIDOLAM N 300MG/150MG/200MG TABLET_2
ZIDOLAM N 300MG/150MG/200MG TABLET_1
15% Off

Zidolam N Tablet

Prescription Required

Salt Composition : Lamivudine,nevirapine,zidovudine

Manufacturer : HETERO HEALTHCARE LTD

Origin of Medicine : India

MRP: 1266.7
Price : 1080
You Save : 187 (15%)

60 Tablet(s) In A Bottle

Pincode
Delivery By -

Introduction to Zidolam N Tablet

Zidolam N 300mg/150mg/200mg Tablet contains the active ingredient Lamivudine + Nevirapine + Zidovudine. It is a combination of three antiretroviral medicines. Lamivudine and Zidovudine mainly belong to the class of medications called nucleoside/nucleotide reverse transcriptase inhibitors. Nevirapine belongs to the class of medication called non-nucleoside reverse transcriptase inhibitors. It is used to treat HIV-1 infection.

This tablet is not advised for patients with anemia (low red blood cells) or neutropenia (low white blood cells). Inform your doctor if you have any liver disease, including hepatitis B or C, kidney disease, or are overweight. The administration of this tablet is associated with hematologic toxicity (decrease in blood cells), muscle weakness, liver diseases and infection, and lactic acidosis (acid buildup due to problems in the body's metabolism). This medication is not advised for children less than 35 kg. Lamivudine, Nevirapine, and zidovudine tablets may cause decreased fertility in females. Talk to your physician if you have any concerns about fertility. 

Zidolam N 300mg/150mg/200mg Tablet is not recommended if you are allergic to this drug or any other active substance or if you are pregnant or breastfeeding women. Inform your physician if you have liver issues, hepatitis infection, kidney diseases, or undergoing dialysis. Tell your physician if you have any active skin conditions such as rash. This tablet can interact with certain medications, potentially affecting their efficacy or increasing the risk of side effects. It's necessary to inform your doctor about all your medications, including prescription, over-the-counter, and herbal supplements, to ensure no potential interactions.


Uses of Zidolam N Tablet

  • HIV-1 Infection

Therapeutic Effects of Zidolam N Tablet

Zidolam N 300mg/150mg/200mg Tablet is a combination of three antiretroviral medicines. Lamivudine and Zidovudine work by inhibiting the reverse transcriptase enzyme of HIV, restricting viral genome replication, and reducing the production of new infectious viral particles. It mainly interferes with reverse transcription and inhibits the spread of HIV. Nevirapine directly binds to reverse transcriptase (RT) and blocks RNA-dependent and DNA-dependent polymerase activities by disrupting the enzyme.


Interaction of Zidolam N Tablet with other drugs

Inform your healthcare provider about all your medicines, including prescription, over-the-counter, nutritional, supplements, and herbal products. Certain medications, including ganciclovir, interferon alfa, and ribavirin, may exacerbate the toxicity of zidovudine interaction with Zidolam N 300mg/150mg/200mg Tablet and reduce its effectiveness by causing undesirable side effects.


More Information about Zidolam N Tablet

  • Store Zidolam N 300mg/150mg/200mg Tablet below 30°C
  • Keep the medicine out of reach of children and pets

How to consume Zidolam N Tablet

Take the Zidolam N 300mg/150mg/200mg Tablet as advised by your physician. Swallow the tablets whole and intact. This tablet should be taken with food. Do not crush, chew, or open the medicine. Your physician will decide the correct dosage and duration based on age, body weight, and disease condition. Only stop taking the medicine if your doctor advises you to stop.


Safety Advices for Zidolam N Tablet

Image Not Available  

Pregnancy

  

Do not take Zidolam N 300mg/150mg/200mg Tablet if you are in your first trimester because this may harm the unborn baby. Inform your physician if you are pregnant, suspecting, or planning to get pregnant during the treatment.

Image Not Available  

Breast Feeding

  

Breastfeeding is not recommended in patients taking Zidolam N 300mg/150mg/200mg Tablet because the medicine passes into the breast milk in small amounts and may harm your baby. Do not breastfeed during the treatment. 

Image Not Available  

Lungs

  

It is unknown whether Zidolam N 300mg/150mg/200mg Tablet is safe for patients with lung diseases. Inform your physician if you have any lung diseases before initiating the therapy.

Image Not Available  

Liver

  

Zidolam N 300mg/150mg/200mg Tablet should be cautiously used in patients with liver diseases. Dose adjustments are necessary. However, inform your physician of any liver diseases before initiating the therapy.

Image Not Available  

Alcohol

  

It is unknown whether consuming alcohol while taking Zidolam N 300mg/150mg/200mg Tablet is safe. Please speak with your physician.

Image Not Available  

Driving

  

It is unknown whether Zidolam N 300mg/150mg/200mg Tablet alters the ability to drive or operate heavy machinery. If you feel sleepy or dizzy, avoid driving and consult your doctor. 


Side Effects of Zidolam N Tablet

Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them.

Serious

  • Lactic acidosis (breathing difficulties along with weakness in limbs, stomach pain, vomiting, and drowsiness)
  • Severe skin reactions and rash (blisters, red or inflamed eyes, swelling of the face, mouth sores, joint aches, fever, tiredness)
  • Liver problems (yellowing of skin, eyes, fever, tea-colored urine, light-colored stools, pain in right side of ribs, loss of appetite)
  • Osteonecrosis (stiffness and pain in joints, difficulty moving)
  • Symptoms of muscle weakness or infection
  • Loss of fat from legs, face, and arms

 Common

  • Nausea
  • Diarrhea
  • Headache, dizziness
  • Cough
  • Difficulty sleeping

Word of Advice

Follow your doctor's instructions concerning high-risk activities such as unprotected sex and personal items with body fluids or blood on them, like toothbrushes, razor blades, and needles. It is advised to practice safe sex by using a condom to lower the chance of sexual contact with semen, blood, or vaginal secretions. If you forgot to take the Zidolam N 300mg/150mg/200mg Tablet, take your next dose at the scheduled time. Do not take a double dose to make up for a forgotten dose.


FAQs

Q 1. Can I stop taking Zidolam N 300mg/150mg/200mg Tablet once I feel better?

No, continuing this Zidolam N 300mg/150mg/200mg Tablet as prescribed is important, even if you feel better. Stopping or interrupting treatment can lead to viral rebound and the development of drug resistance.

Q 2. Can Zidolam N 300mg/150mg/200mg Tablet cure HIV?

No, Zidolam N 300mg/150mg/200mg Tablet cannot cure HIV. They are used as part of combination antiretroviral therapy (ART) to suppress the virus, improve the immune system, and prevent the progression of HIV infection. ART is a lifelong treatment for HIV.

Q 3. Can Zidolam N 300mg/150mg/200mg Tablet prevent HIV transmission during unprotected sex?

While Zidolam N 300mg/150mg/200mg Tablet is effective in managing HIV infection in individuals who are already HIV-positive, they are not intended to prevent HIV transmission. It is necessary to use preventive measures like condoms to reduce the chance of acquiring HIV.

Q 4. Does Zidolam N 300mg/150mg/200mg Tablet cause bone marrow suppression?

Yes, this Zidolam N 300mg/150mg/200mg Tablet may cause bone marrow suppression. Inform your physician if you experience any changes in your blood reports, such as increased or decreased RBC and WBC

Q 5. Can Zidolam N 300mg/150mg/200mg Tablet be given to kidney failure patients?

Zidolam N 300mg/150mg/200mg Tablet should be mainly used with caution in patients with kidney diseases. Inform your physician if you have any kidney diseases before initiating the treatment


Fact Box of Zidolam N Tablet

Molecule name:  Lamivudine + Nevirapine + Zidovudine 

Therapeutic class:  Anti-retroviral 

Pharmacological class: 

Lamivudine + Zidovudine - Nucleoside reverse transcriptase inhibitor (NRTI)

Nevirapine - Non-nucleoside reverse transcriptase inhibitor (Non-NRTI)

Indications: HIV-1 infection 


References

  1. Micro Labs USA Inc, US Food and Drug Administration,[ Revised on August 2018] [ Accessed on 19th May 2023], https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/205626s000lbl.pdf
  2. Lamivudine, Nevirapine, Zidovudine. South Ruislip, Middlesex: Aurobindo Pharma - Milpharm Ltd. Prescribing information. Available at: https://www.accessdata.fda.gov/drugsatfda_docs/pepfar/021939PI.pdf   [ Accessed on 19th May 2023].
  3. HIV drug resistance database. Available at: https://hivdb.stanford.edu/pages/linksPages/NVP_3TC_AZT_GenericCombination.pdf  [ Accessed on 19th May 2023].
  4. KD Tripathi, Essentials of Medical Pharmacology, Antiviral drugs,7th edition, 2013, 806 - 811.
  5. Goodman & Gilman's, The Pharmacological Basis of Therapeutics, Antiretroviral agents and treatment of HIV infection, 12th edition, 2011, 1632-1644.

Disclaimer

MrMed’s primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on MrMed. Our mission is to support, not replace, the doctor-patient relationship.